These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19667308)

  • 21. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Data mining and statistically guided clinical review of adverse event data in clinical trials.
    Southworth H; O'Connell M
    J Biopharm Stat; 2009 Sep; 19(5):803-17. PubMed ID: 20183445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prohibition on shocking apparent asystole: a history and critique of the argument.
    Stewart JA
    Am J Emerg Med; 2008 Jun; 26(5):618-22. PubMed ID: 18534295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Practical guidelines for nutritional management of burn injury and recovery'--a guideline based on expert opinion but not including RCTs.
    Berger MM; Raffoul W; Shenkin A
    Burns; 2008 Feb; 34(1):141-3. PubMed ID: 17870243
    [No Abstract]   [Full Text] [Related]  

  • 25. The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints.
    Lassere MN
    Stat Methods Med Res; 2008 Jun; 17(3):303-40. PubMed ID: 17925313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical guidelines development and usage: a critical insight and literature review: thyroid disease diagnostic algorithms.
    Murgić J; Salopek D; Prpić M; Jukić T; Kusić Z
    Coll Antropol; 2008 Dec; 32(4):1283-90. PubMed ID: 19149242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges for randomized controlled trials in nephrology: illustrations in vascular access science and care.
    Lok CE; Moist LM
    J Nephrol; 2007; 20(6):632-45. PubMed ID: 18046665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reflection of the evidence-based medicine's principles in the Russian consensus documents on angiology and vascular surgery].
    Pokrovskiĭ AV; Sapelkin SV
    Angiol Sosud Khir; 2009; 15(2):7-10. PubMed ID: 19806933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma.
    Johnson SR; Feldman BM; Pope JE; Tomlinson GA
    J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trussed in evidence? Ambiguities at the interface between clinical evidence and clinical practice.
    Healy D
    Transcult Psychiatry; 2009 Mar; 46(1):16-37. PubMed ID: 19293278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mathematical proof and example that Bayes's Theorem is fundamental to actuarial estimates of sexual recidivism risk.
    Donaldson T; Wollert R
    Sex Abuse; 2008 Jun; 20(2):206-17. PubMed ID: 18490482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are guidelines on use of colony-stimulating factors in solid cancers flawed?
    Haines IE; Olver I
    Intern Med J; 2009 Apr; 39(4):259-62. PubMed ID: 19402867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO.
    Kahan NR; Kahan E; Waitman DA; Kitai E; Chintz DP
    Acad Med; 2009 Sep; 84(9):1217-25. PubMed ID: 19707060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing intervention effects in a community-based trial to reduce self-harm: a methodological case study.
    Congdon P; Clarke T
    Public Health; 2005 Nov; 119(11):1011-5. PubMed ID: 16084542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bayesian decision support model for assessment of endodontic treatment outcome.
    Suebnukarn S; Rungcharoenporn N; Sangsuratham S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Sep; 106(3):e48-58. PubMed ID: 18602284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evidence-based dermatology: a synopsis].
    Manríquez Moreno JJ
    Actas Dermosifiliogr; 2009 Mar; 100(2):89-99. PubMed ID: 19445872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining randomized and non-randomized evidence in clinical research: a review of methods and applications.
    Verde PE; Ohmann C
    Res Synth Methods; 2015 Mar; 6(1):45-62. PubMed ID: 26035469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When to randomize, or 'Evidence-based medicine needs medicine-based evidence'.
    Concato J
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():6-12. PubMed ID: 22552974
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence-based medicine in wound care: time for a new paradigm.
    Carter MJ; Warriner RA
    Adv Skin Wound Care; 2009 Jan; 22(1):12-6. PubMed ID: 19096278
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk stratification in surgically repaired tetralogy of Fallot.
    Khairy P; Dore A; Poirier N; Marcotte F; Ibrahim R; Mongeon FP; Mercier LA
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):755-62. PubMed ID: 19589112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.